These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22342816)

  • 1. Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action.
    Zhu HJ; Appel DI; Gründemann D; Richelson E; Markowitz JS
    Pharmacol Res; 2012 Apr; 65(4):491-6. PubMed ID: 22342816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
    Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of organic cation transporter 3 (SLC22A3) and amphetamine.
    Zhu HJ; Appel DI; Gründemann D; Markowitz JS
    J Neurochem; 2010 Jul; 114(1):142-9. PubMed ID: 20402963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action.
    Wang K; Sun S; Li L; Tu M; Jiang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():90-8. PubMed ID: 24657329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
    Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
    Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compound, organic cation transporter 3 detection agent and organic cation transporter 3 activity inhibitor, WO2015002150 A1: a patent evaluation.
    Hu T; Wang L; Pan X; Qi H
    Expert Opin Ther Pat; 2016 Aug; 26(8):857-60. PubMed ID: 27097290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells.
    Salomon JJ; Endter S; Tachon G; Falson F; Buckley ST; Ehrhardt C
    Eur J Pharm Biopharm; 2012 Jun; 81(2):351-9. PubMed ID: 22426135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies.
    Macdonald C; Shao D; Oli A; Agu RU
    J Drug Target; 2013 Jan; 21(1):97-106. PubMed ID: 23050869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.
    Massmann V; Edemir B; Schlatter E; Al-Monajjed R; Harrach S; Klassen P; Holle SK; Sindic A; Dobrivojevic M; Pavenstädt H; Ciarimboli G
    Pflugers Arch; 2014 Mar; 466(3):517-27. PubMed ID: 23982114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.
    Solbach TF; Grube M; Fromm MF; Zolk O
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):409-17. PubMed ID: 21697722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.
    Alim K; Moreau A; Bruyère A; Jouan E; Denizot C; Nies AT; Parmentier Y; Fardel O
    Fundam Clin Pharmacol; 2021 Oct; 35(5):919-929. PubMed ID: 33523504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
    Duan H; Wang J
    J Pharmacol Exp Ther; 2010 Dec; 335(3):743-53. PubMed ID: 20858707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.
    Ayala-Lopez N; Jackson WF; Burnett R; Wilson JN; Thompson JM; Watts SW
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1904-14. PubMed ID: 26432838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
    Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
    Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice.
    Schmitt A; Mössner R; Gossmann A; Fischer IG; Gorboulev V; Murphy DL; Koepsell H; Lesch KP
    J Neurosci Res; 2003 Mar; 71(5):701-9. PubMed ID: 12584728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of organic cation transporter 3 expressed in human placenta.
    Sata R; Ohtani H; Tsujimoto M; Murakami H; Koyabu N; Nakamura T; Uchiumi T; Kuwano M; Nagata H; Tsukimori K; Nakano H; Sawada Y
    J Pharmacol Exp Ther; 2005 Nov; 315(2):888-95. PubMed ID: 16081676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands.
    Schneider E; Machavoine F; Bricard-Rignault R; Levasseur M; Petit-Bertron AF; Gautron S; Ribeil JA; Launay JM; Mecheri S; Côté F; Dy M
    J Allergy Clin Immunol; 2011 Oct; 128(4):864-871.e2. PubMed ID: 21636115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General Overview of Organic Cation Transporters in Brain.
    Koepsell H
    Handb Exp Pharmacol; 2021; 266():1-39. PubMed ID: 33782773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.
    Duan H; Hu T; Foti RS; Pan Y; Swaan PW; Wang J
    Drug Metab Dispos; 2015 Nov; 43(11):1773-80. PubMed ID: 26285765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.